Betahistine for symptoms of vertigo

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 8, 2013, Pages

  Murdin, Louisa ^a,b   Hussain, Kiran ^a   Schilder, Anne G M ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETAHISTINE;

ARTICLE; CLINICAL OUTCOME; CLINICAL PROTOCOL; DISEASE DURATION; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFECT; FALLING; FREQUENCY; HUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; SYSTEMATIC REVIEW; VERTIGO; VESTIBULAR TEST;

EID: 84976336709     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD010696     Document Type: Article

References (24)

1. AAO-HNS. Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Meniere's disease, American Academy of Otolaryngology - Head and Neck Foundation. Otolaryngology - Head and Neck Surgery 1995;113:181-5.
2. Agus S, Benecke H, Thum C, Strupp M. Clinical and demographic features of vertigo: findings from the REVERT registry. Frontiers in Neurology 2013;4:48.
3. Barak N. Betahistine: what's new on the agenda?. Expert Opinion on Investigational Drugs 2008;17:795-804.
4. BisdorffA, Von Brevern M, Lempert T, Newman-Toker DE. Classification of vestibular symptoms: towards an international classification of vestibular disorders. Journal of Vestibular Research: Equilibrium & Orientation 2009;19:1-13.
5. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
6. Hannaford PC, Simpson JA, Bisset AF, Davis A, McKerrow W, Mills R. The prevalence of ear, nose and throat problems in the community: results from a national cross-sectional postal survey in Scotland. Family Practice 2005;22:227-33.
7. Hillier SL, McDonnell M. Vestibular rehabilitation for unilateral peripheral vestibular dysfunction. Cochrane Database of Systematic Reviews 2011, Issue 2. [DOI: 10.1002/14651858.CD005397.pub3]
8. Hilton M, Pinder D. The Epley (canalith repositioning) manoeuvre for benign paroxysmal positional vertigo. Cochrane Database of Systematic Reviews 2004, Issue 2. [DOI: 10.1002/14651858.CD003162.pub2]
9. Hunt WT, Zimmermann EF, Hilton MP. Modifications of the Epley (canalith repositioning) manoeuvre for posterior canal benign paroxysmal positional vertigo (BPPV). Cochrane Database of Systematic Reviews 2012, Issue 4. [DOI: 10.1002/14651858.CD008675.pub2]
10. Ihler F, Bertlich M, Sharaf K, Strieth S, Strupp M, Canis M. Betahistine exerts a dose-dependent effect on cochlear stria vascularis blood flow in guinea pigs in vivo. Plos One 2012;7(6):e39086.
11. James A, Burton MJ. Betahistine for Ménière's disease or syndrome. Cochrane Database of Systematic Reviews 2001, Issue 1. [DOI: 10.1002/14651858.CD001873]
12. Karatas M. Vascular vertigo: epidemiology and clinical syndromes. Neurologist 2010;17:1-10.
13. Kruschinski C, Kersting M, Breull A, Kochen MM, Koschack J, Hummers-Pradier E. Frequency of dizziness-related diagnoses and prescriptions in a general practice database. Zeitschrift fur Evidenz Fortbildung und Qualitat im Gesundheitswesen 2008;102:313-9.
14. Lempert T, Olesen J, Furman J, Waterston J, Seemungal B, Carey J, et al. Vestibular migraine: diagnostic criteria. Journal of Vestibular Research: Equilibrium & Orientation 2012;22:167-72.
15. Linde K, Rossnagel K. Propranolol for migraine prophylaxis. Cochrane Database of Systematic Reviews 2004, Issue 2. [DOI: 10.1002/14651858.CD003225.pub2]
16. Martinez DM. The effect of Serc (betahistine hydrochloride) on the circulation of the inner ear in experimental animals. Acta Oto-Laryngologica. Supplement 1972;305:29-47.
17. Nazareth I, Yardley L, Owen N, Luxon L. Outcome of symptoms of dizziness in a general practice community sample. Family Practice 1999;16:616-8.
18. Neuhauser HK, von Brevern M, Radtke A, Lezius F, Feldmann M, Ziese T, et al. Epidemiology of vestibular vertigo: a neurotologic survey of the general population. Neurology 2005;65:898-904.
19. Newman-Toker DE, Dy FJ, Stanton VA, Zee DS, Calkins H, Robinson KA. How often is dizziness from primary cardiovascular disease true vertigo? A systematic review. Journal of General Internal Medicine 2008;23:2087.
20. Pathy J, Menon G, Reynolds A, Van Strik R. Betahistine hydrochloride (Serc) in cerebrovascular disease a placebo-controlled study. Age and Ageing 1977;6(3):179-84.
21. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
22. Strupp M, Brandt T. Peripheral vestibular disorders. Current Opinion in Neurology 2013;26:81-9.
23. Timmerman H. Pharmacotherapy of vertigo - any news to be expected?. Acta Oto-Laryngologica 1994;513:28-32.
24. Wiltink J, Tschan R, Michal M, Subic-Wrana C, Eckhardt-Henn A, Dieterich M, et al. Dizziness: anxiety, health care utilization and health behavior--results from a representative German community survey. Journal of Psychosomatic Research 2009;66:417-24.